Viatris Inc. (VTRS)
undefined
undefined%
At close: undefined
12.63
-0.04%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Viatris Inc. operates as a healthcare company worldwide.

The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.

It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).

The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health.

It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions.

The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.

It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE.

The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd.

Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Viatris Inc.
Viatris Inc. logo
Country United States
IPO Date Mar 17, 1980
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 32,000
CEO Scott Andrew Smith Ph.D.

Contact Details

Address:
1000 Mylan Boulevard
Canonsburg, Pennsylvania
United States
Website https://www.viatris.com

Stock Details

Ticker Symbol VTRS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001792044
CUSIP Number 92556V106
ISIN Number US92556V1061
Employer ID 83-4364296
SIC Code 2834

Key Executives

Name Position
Scott Andrew Smith Ph.D. Chief Executive Officer & Director
Andrew Enrietti Chief People Officer
Brian S. Roman Chief Legal Officer
Ramkumar V. Rayapureddy Chief Information Officer
Theodora Mistras Chief Financial Officer
Derek Glover Chief Quality Officer
Dr. Jeffrey Nau MMS, Ph.D. President of Viatris Eye Care Division
Lara Ramsburg Chief Corporate Affairs Officer
Menassie Taddese M.B.A. President of Emerging Markets
Paul B. Campbell Chief Accounting Officer, Senior Vice President & Corporate Controller

Latest SEC Filings

Date Type Title
Dec 06, 2024 8-K Current Report
Nov 12, 2024 4 Filing
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 07, 2024 10-Q Quarterly Report
Nov 07, 2024 8-K Current Report
Oct 25, 2024 ARS Filing
Oct 25, 2024 DEFA14A Filing
Oct 25, 2024 DEF 14A Filing
Oct 25, 2024 4 Filing
Sep 27, 2024 8-K Current Report